What LPs can do in GP-led deals

Proskauer Rose’s Howard Beber and Michael Suppappola tell Secondaries Investor that despite having healthy scepticism, LPs are increasingly judging each deal on its merits.

To view this content you must sign in:

Not yet registered? Join today to access Secondaries Investor's industry insights and updates.